Current Editions
Building bridges between biomedical stakeholders: guiding principle for new NCI director
A Q&A with W. Kimryn Rathmell as she takes the reins at NCI
Product Development
Product Development
Innate immune activators among first-in-human debuts at AACR
Spotlight on early-stage solid tumor trials with emerging innate immune targets: ALPK1 and ENPP1
Finance
Venture report: Arch, Foresite $1B AI play Xaira starting with Baker lab’s de novo biologics
Plus rounds for Rubedo, Flindr, Endeavor, SynOx and more
Management Tracks
Randy Teel named CBO at Arvinas
Plus: Meenu Chhabra Karson becomes chair at Harness, and an update from Ontada
BioCentury ISSN 1097-7201